Evidation

?? We have big news! We’re excited to announce that Leslie Oley Wilberforce has been appointed CEO of Evidation! ?? Since joining the company in 2015, Leslie has been instrumental in shaping Evidation’s trajectory as a market leader in real-world data and health research—leading the creation of our enterprise product and platform and forging partnerships with global leaders in pharma, technology, and public health. Her leadership has been central to building Evidation into a trusted, participant-first platform that is redefining how real-world data is collected and applied to drive scientific innovation. We want to express our deep gratitude to Christine Lemke, whose vision and leadership transformed Evidation from an idea into a company that connects directly with millions of individuals to measure, understand, and improve health in everyday life. We’re thrilled that she will continue to be part of Evidation as a Board Member and advisor. With Leslie at the helm, we’re excited for what’s ahead! ?? Please join us in congratulating her on this well-deserved new role, and stay tuned to hear more from Leslie—including where she’ll be speaking in the coming weeks. ?? Read more in the press release here: https://lnkd.in/g68XwNus

Conventional real-world data doesn’t tell the full story. Get the real story about weight management, obesity, and GLP-1s through a direct, longitudinal connection with individuals. Learn more: https://lnkd.in/ghpJm4kq

?? Missed our recent webinar? No problem—you can catch it on demand here: https://lnkd.in/gqrRRP86 Ernesto Ramirez and Abigail Levine, PhD, shared real-world insights about the experiences of more than 10,000 individuals who reported having taken GLP-1s. ?? There's a lot more to learn. If you have questions that you'd like to explore with this population, we'd love to talk. Reach out to our team: https://lnkd.in/dYh7XKfu

??? We're less than a week away from our webinar, where we’ll share learnings from GLP-1 users based on real-world data collected directly from 140,000+ individuals actively sharing data from their weight management journeys. We'll also discuss what’s ahead, and how you can access insights from this population. Register here: https://lnkd.in/gQEc59iM

Great insights from Jonah Comstock's conversation with Phil Johnson on how Evidation's direct-to-individual approach is transforming real-world data collection and advancing healthcare. By connecting directly with individuals, we're able to collect data that can answer some of the big "whys" behind health and disease, driving powerful discoveries in drug development and healthcare. If you want to learn more, contact us: https://lnkd.in/dYh7XKfu

??Did you know? Out of 6,000+ individuals prescribed a GLP-1, 40%+ received their prescription from a non-primary provider. These experiences are unaccounted for in traditional real-world data. ?? Join our webinar on February 25th with Ernesto Ramirez and Abigail Levine, PhD to learn what else we uncovered about GLP-1 users, what’s possible with real-world data captured through a direct connection to individuals, and how you can unlock new insights and evidence from your patient populations. Register here: https://lnkd.in/gQEc59iM

Earlier this month, during Fierce’s JPM Week, Evidation CCO Phil Johnson participated in the panel "Unlocking the Power of Healthcare Data- Advancing Access and Connectivity to Drive Patient Outcomes." He shared his thoughts on the critical role of real-world data collected directly from patients and why it’s essential for advancing patient outcomes. This Thursday at #PMWC2025, Phil will take the stage to discuss how real-world data collected directly from patients is an essential input for AI to transform health outcomes and research. As AI-driven insights continue to shape the future of precision medicine, ensuring timely, complete, and patient-centered data will be key to unlocking its full potential. Let us know if you’ll be there, or learn more and join us: https://lnkd.in/dk2yvMDy #PMWC #PrecisionMedicine #AI #RealWorldData

Heading to SCOPE Summit next week? Let’s talk about how real-world data—collected through a direct connection to 5 million individuals—can transform your trial strategy. From optimizing study design to improving recruitment and retention, real-world insights drive faster, more efficient trials with stronger outcomes. Reach out to our team to connect: https://lnkd.in/dYh7XKfu _____ Mark Kunsman, Monika Jain #SCOPEsummit #SCOPE2025 #RWD #RealWorldData

Recently, the FDA issued new draft guidance (https://lnkd.in/eMJr3eq3) for developing drugs aimed at reducing body weight in individuals who are overweight or obese. While BMI remains the primary metric for assessing efficacy, the FDA specifically calls out functional impacts—like mobility or physical activity—as key secondary endpoints, stressing they must be meaningful to both patients and regulators. ?? But how do we determine what’s meaningful to patients? We ask them. Since July 2024, Evidation has been collecting real-world data directly from 130,000+ individuals on their weight management journeys, including more than 5,000 individuals actively taking GLP-1s, offering unique insights into patient experiences. As the obesity treatment landscape evolves, patient-centric insights will be essential for regulatory and clinical decision-making, as well as driving commercial success and market differentiation. ?? Want to learn more? Contact us here: https://lnkd.in/g8ukZev5 #RealWorldData #RealWorldEvidence #Obesity #Evidation

Fresh off an incredible week at JPM, we're excited for Phil Johnson to be speaking at the 24th PMWC - Precision Medicine World Conference #PMWC2025 from February 5-7, 2025, at the Santa Clara Convention Center, CA! Co-hosted by Stanford and UCSF, PMWC is the premier forum for leaders driving the future of healthcare. Phil will be speaking in the AI Models for RWE/D Applications Track, discussing how we can leverage AI and real-world data to advance patient-centered outcomes. We're looking forward to joining top experts in exploring how AI-powered insights can transform health outcomes and research. With 400+ speakers, 12 tracks, and an incredible lineup of honorees—including Nobel Laureates Carolyn Bertozzi, Drew Weissman, and Carol Greider, NVIDIA’s CEO Jensen Huang, and FDA Commissioner Rob Califf—#PMWC2025 is an unparalleled opportunity to share breakthroughs and foster collaborations that will shape the future of precision medicine. Learn more and join us: https://lnkd.in/dk2yvMDy Tal Behar #PMWC #PrecisionMedicine #AI #RealWorldData